|Bid||498.52 x 1000|
|Ask||503.02 x 800|
|Day's range||496.88 - 513.45|
|52-week range||462.61 - 832.70|
|Beta (5Y monthly)||0.92|
|PE ratio (TTM)||N/A|
|Earnings date||27 Jul 2022 - 01 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||711.67|
HERCULES, Calif., June 27, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today released its inaugural corporate sustainability report.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Investors are optimistic about Bio-Rad's (BIO) strong growth in its key product lines across several geographies.